@article{10.37349/emed.2023.00147,
abstract = {Gastrointestinal (GI) cancer is one of the leading causes of death that affect many patients around the world. The coronavirus disease 2019 (COVID-19) pandemic significantly impacted our healthcare system in large that diagnosis and management of GI cancer have suffered with a reduction in cancer screening. This review will describe the current practices of cancer screening during COVID-19 pandemic and summarize how each GI cancer (esophageal, gastric, colorectal, and hepatocellular cancers) has been affected by COVID-19. World widely there has been a decreasing trend in screening, diagnosis, and management of GI cancers during the COVID-19 pandemic. Many healthcare institutions are now observing the effect of this change and implementing practice variations to adapt to the pandemic.},
author = {Yoo, Byung Soo and Patel, Ankit and Houston, Kevin V. and Vargas, Alejandra and Vilela Sangay, Ana Rosa and D’Souza, Steve M. and Johnson, David A.},
doi = {10.37349/emed.2023.00147},
journal = {Exploration of Medicine},
pages = {356--362},
title = {{The impact of COVID-19 pandemic on diagnosis and management of gastrointestinal cancers}},
url = {https://www.explorationpub.com/Journals/em/Article/1001147},
volume = {4},
year = {2023},
number = {3}
}